tiprankstipranks
AK Medical Holdings Ltd. (HK:1789)
:1789
Hong Kong Market
1789
AK Medical Holdings Ltd.
RESEARCH TOOLSreports
Want to see HK:1789 full AI Analyst Report?

AK Medical Holdings Ltd. (1789) Ratios

1 Followers

AK Medical Holdings Ltd. Ratios

HK:1789's free cash flow for Q4 2025 was ¥0.62. For the 2025 fiscal year, HK:1789's free cash flow was decreased by ¥ and operating cash flow was ¥0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.10 4.10 3.65 3.96 4.73
Quick Ratio
 3.41 3.41 2.83 2.77 3.81
Cash Ratio
 0.57 0.57 0.59 0.66 1.43
Solvency Ratio
 0.55 0.57 0.49 0.45 0.54
Operating Cash Flow Ratio
 0.34 0.64 0.76 0.07 0.56
Short-Term Operating Cash Flow Coverage
 1.68 3.10 7.46 1.59 0.00
Net Current Asset Value
¥ 1.95B¥ 1.95B¥ 1.48B¥ 1.36B¥ 1.53B
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.03 0.03 0.01
Debt-to-Equity Ratio
 0.05 0.05 0.04 0.04 0.02
Debt-to-Capital Ratio
 0.05 0.05 0.04 0.03 0.02
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.01 0.00
Financial Leverage Ratio
 1.26 1.26 1.26 1.26 1.24
Debt Service Coverage Ratio
 2.86 2.96 5.31 12.10 132.17
Interest Coverage Ratio
 145.74 127.13 325.87 164.32 101.19
Debt to Market Cap
 0.02 0.02 0.02 <0.01 0.00
Interest Debt Per Share
 0.13 0.13 0.09 0.08 0.04
Net Debt to EBITDA
 -0.51 -0.49 -0.68 -0.76 -1.82
Profitability Margins
Gross Profit Margin
60.54%60.54%60.03%61.66%60.49%
EBIT Margin
25.22%25.22%22.34%21.25%23.05%
EBITDA Margin
30.38%31.39%27.60%29.56%30.69%
Operating Profit Margin
25.22%25.22%22.34%19.33%20.91%
Pretax Profit Margin
26.64%26.64%23.75%21.13%22.84%
Net Profit Margin
22.87%22.87%20.35%16.65%19.46%
Continuous Operations Profit Margin
22.87%22.87%20.35%16.65%19.46%
Net Income Per EBT
85.85%85.85%85.65%78.79%85.22%
EBT Per EBIT
105.64%105.64%106.33%109.28%109.23%
Return on Assets (ROA)
9.25%9.25%8.21%6.06%7.38%
Return on Equity (ROE)
12.01%11.64%10.38%7.61%9.13%
Return on Capital Employed (ROCE)
12.44%12.44%10.98%8.44%9.41%
Return on Invested Capital (ROIC)
10.22%10.22%9.16%6.56%7.97%
Return on Tangible Assets
9.77%9.77%8.73%6.50%8.17%
Earnings Yield
5.72%5.92%5.39%2.84%2.14%
Efficiency Ratios
Receivables Turnover
 2.13 2.13 2.33 1.99 1.93
Payables Turnover
 4.21 4.21 3.54 2.40 2.68
Inventory Turnover
 1.27 1.27 1.10 0.70 1.03
Fixed Asset Turnover
 2.12 2.12 1.97 2.15 2.87
Asset Turnover
 0.40 0.40 0.40 0.36 0.38
Working Capital Turnover Ratio
 0.76 0.82 0.88 0.70 0.68
Cash Conversion Cycle
 370.97 370.97 384.60 549.59 406.27
Days of Sales Outstanding
 170.99 170.99 156.34 183.54 189.21
Days of Inventory Outstanding
 286.62 286.62 331.42 518.30 353.34
Days of Payables Outstanding
 86.64 86.64 103.16 152.24 136.27
Operating Cycle
 457.61 457.61 487.75 701.84 542.54
Cash Flow Ratios
Operating Cash Flow Per Share
 0.20 0.37 0.40 0.03 0.22
Free Cash Flow Per Share
 0.18 0.28 0.26 -0.14 0.11
CapEx Per Share
 0.03 0.09 0.15 0.17 0.11
Free Cash Flow to Operating Cash Flow
 0.87 0.75 0.64 -4.78 0.50
Dividend Paid and CapEx Coverage Ratio
 2.21 2.40 2.17 0.13 1.67
Capital Expenditure Coverage Ratio
 7.56 4.07 2.78 0.17 2.00
Operating Cash Flow Coverage Ratio
 1.57 2.89 4.54 0.40 6.26
Operating Cash Flow to Sales Ratio
 0.15 0.28 0.34 0.03 0.23
Free Cash Flow Yield
3.34%5.52%5.69%-2.53%1.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.48 16.90 18.56 35.22 46.83
Price-to-Sales (P/S) Ratio
 3.97 3.87 3.78 5.86 9.11
Price-to-Book (P/B) Ratio
 2.03 1.97 1.93 2.68 4.27
Price-to-Free Cash Flow (P/FCF) Ratio
 29.93 18.13 17.58 -39.56 79.11
Price-to-Operating Cash Flow Ratio
 26.14 13.67 11.27 189.03 39.47
Price-to-Earnings Growth (PEG) Ratio
 1.14 0.84 0.33 -3.17 0.40
Price-to-Fair Value
 2.03 1.97 1.93 2.68 4.27
Enterprise Value Multiple
 12.56 11.82 13.00 19.07 27.88
Enterprise Value
 5.66B 5.50B 4.83B 6.17B 9.00B
EV to EBITDA
 12.56 11.82 13.00 19.07 27.88
EV to Sales
 3.82 3.71 3.59 5.64 8.56
EV to Free Cash Flow
 28.76 17.40 16.71 -38.04 74.27
EV to Operating Cash Flow
 24.96 13.12 10.71 181.75 37.06
Tangible Book Value Per Share
 2.43 2.43 2.19 1.92 1.78
Shareholders’ Equity Per Share
 2.61 2.60 2.36 2.10 2.02
Tax and Other Ratios
Effective Tax Rate
 0.14 0.14 0.14 0.21 0.15
Revenue Per Share
 1.33 1.32 1.21 0.96 0.95
Net Income Per Share
 0.30 0.30 0.25 0.16 0.18
Tax Burden
 0.86 0.86 0.86 0.79 0.85
Interest Burden
 1.06 1.06 1.06 0.99 0.99
Research & Development to Revenue
 0.10 0.10 0.10 0.13 0.11
SG&A to Revenue
 0.28 0.28 0.29 0.12 0.11
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 0.67 1.27 1.41 0.15 1.01
Currency in CNY